Table 2.
Demographics and total number of facial injuries observed during physical examination under anesthesia in this double-blind, placebo-controlled study of gabapentin to reduce fear in cage-confined community cats
| Treatment group |
||||
|---|---|---|---|---|
| Placebo | Low-dose gabapentin | High-dose gabapentin | Total | |
| Gabapentin dose (mg) | 0 | 50 | 100 | |
| Mean dose (mg/kg) | 0 | 16.3 | 35.3 | |
| Dose range (mg/kg) | 0 | 9.2–24.4 | 23.1–47.6 | |
| Sample size | 19 (35.8) | 17 (32.1) | 17 (32.1) | 53 |
| Age (months) | P = 0.90 | |||
| 4–6 | 2 (3.8) | 0 (0.0) | 1 (1.9) | 3 (5.7) |
| 6–9 | 4 (7.5) | 2 (3.8) | 4 (7.5) | 10 (18.9) |
| 9–12 | 3 (5.7) | 6 (11.3) | 5 (9.4) | 14 (26.4) |
| >12 | 10 (18.9) | 9 (17.0) | 7 (13.2) | 26 (49.0) mean = 15 months |
| Mean weight (kg) | P = 0.75 | |||
| 3.0 | 3.4 | 3.0 | 3.1 | |
| Sex | P = 0.77 | |||
| Male intact | 6 (11.3) | 8 (15.1) | 8 (15.1) | 21 (39.6) |
| Female intact | 12 (22.6) | 9 (17.0) | 8 (15.1) | 30 (56.6) |
| Female spayed | 1 (1.9) | 0 (0.0) | 1 (1.9) | 2 (3.8) |
| Facial injuries (detected under anesthesia) | ||||
| Nasal bridge scratch | 1 (1.9) | 5 (9.4) | 5 (9.4) | 11 (20.7) |
| Nasal bridge abrasion | 3 (5.7) | 2 (3.8) | 0 (0.0) | 5 (9.4) |
| Gingival abrasion | 1 (1.9) | 0 (0.0) | 2 (3.8) | 3 (5.7) |
| Facial scratches | 0 (0.0) | 3 (5.7) | 0 (0.0) | 3 (5.7) |
| Lip scratch | 0 (0.0) | 1 (1.9) | 1 (1.9) | 2 (3.8) |
| Lingual abrasion | 0 (0.0) | 1 (1.9) | 1 (1.9) | 2 (3.8) |
| Fractured tooth | 1 (1.9) | 0 (0.0) | 0 (0.0) | 1 (1.9) |
| Epistaxis | 1 (1.9) | 0 (0.0) | 0 (0.0) | 1 (1.9) |
| Deep lacerations | 0 (0.0) | 1 (1.9) | 0 (0.0) | 1 (1.9) |
| Total cats injured per group | 7 (13.2) | 9 (17.0) | 7 (13.2) | 23 (43.4) |
Data are n (%) unless otherwise indicated